Your session is about to expire
← Back to Search
Lifestyle Changes for Obesity (SILC Trial)
SILC Trial Summary
This trial aims to reduce obesity, diabetes, and high blood pressure in African American women over 30 in Alabama and Mississippi by promoting healthy weight loss with evidence-based programs.
SILC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSILC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SILC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I live, work, or worship in one of the specified communities and don't plan to move for the next 18 months.My BMI is over 25 and I have been diagnosed with pre-diabetes or hypertension in the last 2 years.You identify yourself as Black and/or African American.I am 30 years old or older.You are willing to be part of the study for 18 months.You identify yourself as Black and/or African American.
- Group 1: Educational Group Weight Loss Classes
- Group 2: Educational Group Weight Loss Classes PLUS Home Gardening Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor still open to new participants?
"According to clinicaltrials.gov, this specific research endeavour is no longer actively searching for individuals to participate in its trials. The study was launched on February 1st 2023 and last updated November 21st 2022; however, there are many other studies with open recruitment periods presently available."
What is the chief aspiration of this research endeavor?
"This trial, which will have measurements taken at 0, 6, 12, and 18 months is focused on Waist Circumference. Secondary metrics to be tracked include Diastolic & Systolic Blood Pressure (measured with a calibrated sphygmomanometer), Fasting Glucose (finger-stick readings) and Cholesterol Levels (LDL/HDL values collected by finger-stick)."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger